A device designed to improve adherence to outpatient parenteral antimicrobial therapy (OPAT) took top prize at the second IDEA Incubator, a competition showcasing inventions, products and devices to improve patient care for infectious diseases, which takes place during IDWeek.
As 12,000 medical doctors, research scientists and public health experts on the front lines of COVID-19, the infectious diseases community will not be silenced nor sidelined amidst a global pandemic. Reports of a campaign to discredit and diminish the role of Dr. Fauci at this perilous moment are disturbing.
While the data to date show some positive signals that convalescent plasma can be helpful in treating individuals with COVID-19, especially if given early in the trajectory of disease, we lack the randomized controlled trial data we need to better understand its utility in COVID-19 treatment.
The Senate Labor, Health and Human Services and State and Foreign Operations Appropriations bills released by the full committee on Nov. 10 provide needed resources to address infectious diseases in the United States and abroad
A paper published Thursday in Clinical Infectious Diseases examines how barriers to appropriate diagnostic tools led to missed opportunities to curb antibiotic resistance and recommends steps to develop and expand the use of tests that can identify resistant bacteria.
The Infectious Diseases Society of America and its HIV Medicine Association welcome President-elect Biden’s selection of Dr. Rochelle Walensky to lead the U.S. Centers for Disease Control and Prevention.
In a worldwide sample, 26% of environmental samples from healthcare and non-healthcare sites tested positive for C. diff strains. Shoe soles had the highest positivity rates, with 45% of samples testing positive for the bacteria.
IDSA supports recommendations made by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices that will allow access to updated COVID-19 vaccines to all people 6 months of age and older.
The nation’s leading infectious diseases professional society, recognizes the largest class of distinguished physicians and scientists from the United States and around the world to be elected as Fellows of IDSA.
The Infectious Diseases Society of America and the International Working Group on the Diabetic Foot today released new guidelines on preventing, diagnosing and treating foot infections in people who have diabetes.
The nation’s leading infectious diseases professional society recognizes this year’s class of distinguished physicians and scientists from the United States and around the world to be elected as Fellows of IDSA. Fellowship in IDSA is one of the highest honors in the field of infectious diseases.